SINGAPORE, April 19, 2006 – A team of researchers at the Institute of Bioengineering and Nanotechnology (IBN) has successfully created artificial fibers with nanometer-sized features that can be used to grow cells and tissue structures.
These ‘fibrous scaffolds’ have been imbued with features of the natural extracellular matrix, the ground substance in which cells are embedded and a vital component in the engineering of human tissues.
This research was recently published in the March issue of the leading journal Advanced Materials (1). The work on the “Three-Dimensional Reconstituted Extracellular Matrix Scaffolds for Tissue Engineering” also won an Outstanding Paper Award at the 12th International Conference on Biomedical Engineering in December 2005 (2).
Scaffolds are ‘templates’ upon which the desired cell type or precursor is seeded for the growth of different tissues. Signaling molecules can also be incorporated into these structures to instruct or regulate cell growth and differentiation. Using IBN’s fibrous scaffolds, tissue engineers, for example, would be able to take a patient’s own cells, grow it into tissue in the lab, and subsequently implant the developed tissue back into the patient.
While much work has been done to engineer suitable scaffolds, conventional production methods involve the use of high temperatures, organic solvents and/or a leaching step to develop porosity. Such conditions compromise the biological activity of proteins, and thus pose problems in the incorporation of biological molecules within the scaffolds.
IBN, however, has been able to create fibers by interfacial polyelectrolyte complexation, which is a mild, aqueous-based process that takes place at ambient temperature. A method called ‘hydroentanglement’ that employs water pressure is then used to entangle the fibers into scaffolds. Previous work in this area was hampered by the tendency of the fibers to clump and form a dense monolith of low porosity. IBN scientists solved this problem by incorporating silica, an inorganic material that is found in simple marine organisms and some forms of glass, effectively crosslinking the fibers to obtain porous 3-D scaffolds. The porosity or permeability of the scaffold is important because a scaffold with a high surface-to-volume ratio provides for better interaction of cells with the matrix, and thus a better environment for the culture of various cell types for tissue engineering.
Results have shown that cells could adhere and grow well on IBN’s fibrous scaffolds after they were incorporated with components such as collagen, fibronectin and cell-adhesion peptides. “We have created scaffolds based on natural polymers and extracellular matrix components that can be specially tailored for the adhesion and proliferation of a variety of cells,” said IBN Principal Research Scientist Dr Andrew Wan, who is the team leader of the project. “Hence, these scaffolds would have many potential applications in the engineering of tissues as implants, or as in vitro models for drug development“.
A US patent has been filed on the invention.
(1) A. C. A. Wan, B. C. U. Tai, K.-J. Leck, and J. Y. Ying, “Silica-Incorporated Polyelectrolyte-Complex Fibers as Tissue-Engineering Scaffolds,” Advanced Materials, 18 (2006), 641-644.
(2) A. C. A. Wan, B. C. U. Tai, K.-J. Leck, S. Pek, S. Gao, and J. Y. Ying, “Three-Dimensional Reconstituted Extracellular Matrix Scaffolds for Tissue Engineering,” 12th International Conference on Biomedical Engineering, Singapore, December 2005. Outstanding Paper Award.
A member of A*STAR’s Biomedical Sciences Institutes (Co. Reg. No. 199702109N)
About the Institute of Bioengineering and Nanotechnology (IBN)
The Institute of Bioengineering and Nanotechnology (IBN) is a member of the Agency for Science, Technology and Research (A*STAR). Established in March 2003, the Institute’s mission is to establish a broad knowledge base and conduct innovative research at the interface of bioengineering and nanotechnology. Positioned at the frontiers of engineering, IBN is focused on creating knowledge and cultivating talent to develop technology platforms that will spur the growth of new industries. IBN also fosters an exciting, multidisciplinary research environment for the training of students and young researchers to spearhead biomedical advancement in Singapore.
For more information on IBN, please log on to www.ibn.a-star.edu.sg.
For media queries, please contact:
Adeline Goh
DID: +65 6824 7004 or HP: +65 9686 3160
Email: [email protected]
Nidyah Sani
DID: +65 6824 7005 or HP: +65 9762 9720
Email: [email protected]
